Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/48327
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Santana Rodríguez, O. E. | en_US |
dc.contributor.author | Morillas Jarillo, C. | en_US |
dc.contributor.author | Esparza Martín, N. | en_US |
dc.contributor.author | Toledo González, A. | en_US |
dc.contributor.author | Checa Andrés, M. D. | en_US |
dc.contributor.author | Martín Sánchez, A. M. | en_US |
dc.date.accessioned | 2018-11-23T20:45:58Z | - |
dc.date.available | 2018-11-23T20:45:58Z | - |
dc.date.issued | 1999 | en_US |
dc.identifier.issn | 0014-2565 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/48327 | - |
dc.description.abstract | Background. The presence of surface antigen of hepatitis B (HBsAg) virus in serum from recently vaccinated adults has been scarcely investigated. In this work, after the detection by chance of seven HBsAg-positive patients on hemodialysis who reported recent hepatitis B vaccination, a prospective study was undertaken to verify the presence and duration of post-vacunal antigenemia.Patients and methods. Nineteen non-selected patients on hemodialysis were followed for serologic markers of hepatitis B, after receiving a dose of the recombinant vaccine (Engerix B) according to their vaccination schedule. Enzyme-immunoassay techniques were used for the study of serologic markers, and the reactivity of HBsAg was confirmed by means of a neutralization assay with specific anti-HBs antibodies.Results. After the administration of one vaccine dose, 31.5% of patients were HBsAg positive at least once. Antigenemia was identified more frequently 2 to 4 days (83.3%) after inmunization. In all cases antigenemia was transient and had cleared after 11 days of vaccination. The follow-up of serologic markers revealed the absence of infection with virus B. Only 16.6% of patients with transient antigenemia responded to vaccination (titer of anti-HBs greater than or equal to 10 mIU/ml), while the corresponding percentage in the group of HBsAg-negative patients was 69.2% (p < 0.05). All patients were HCV and HIV negative.Conclusions. A high frequency of post-vacunal antigenemia is reported in patients on hemodialysis, in absence of virus B infection as well as the possible relationship between the presence of transient antigenemia and the non-responder status. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Revista clínica española (Ed. impresa) | en_US |
dc.source | Revista Clinica Espanola[ISSN 0014-2565],v. 199, p. 198-201 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320102 Genética clínica | en_US |
dc.subject.other | Hepatitis-B Vaccine | en_US |
dc.subject.other | Surface Antigenemia | en_US |
dc.title | Transient HBs antigenemia in patients on hemodialysis | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.scopus | 0032912398 | - |
dc.identifier.isi | 000080545500003 | - |
dc.contributor.authorscopusid | 6506976094 | - |
dc.contributor.authorscopusid | 6504729836 | - |
dc.contributor.authorscopusid | 6507185986 | - |
dc.contributor.authorscopusid | 6507206915 | - |
dc.contributor.authorscopusid | 55663413100 | - |
dc.contributor.authorscopusid | 7005670807 | - |
dc.description.lastpage | 201 | en_US |
dc.description.firstpage | 198 | en_US |
dc.relation.volume | 199 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 31925556 | - |
dc.contributor.daisngid | 32726058 | - |
dc.contributor.daisngid | 472151 | - |
dc.contributor.daisngid | 11714873 | - |
dc.contributor.daisngid | 806389 | - |
dc.contributor.daisngid | 1701503 | - |
dc.description.numberofpages | 4 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Rodriguez, OES | - |
dc.contributor.wosstandard | WOS:Jarillo, CM | - |
dc.contributor.wosstandard | WOS:Martin, NE | - |
dc.contributor.wosstandard | WOS:Gonzalez, AT | - |
dc.contributor.wosstandard | WOS:Andres, MDC | - |
dc.contributor.wosstandard | WOS:Sanchez, AMM | - |
dc.date.coverdate | Abril 1999 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 0,198 | - |
dc.description.jcrq | Q4 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.fullName | Santana Rodríguez, Otilia Évora | - |
crisitem.author.fullName | Martín Sánchez, Antonio Manuel | - |
Colección: | Artículos |
Citas SCOPUSTM
9
actualizado el 13-oct-2024
Citas de WEB OF SCIENCETM
Citations
3
actualizado el 20-feb-2022
Visitas
63
actualizado el 27-jul-2024
Google ScholarTM
Verifica
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.